SeaStar Medical (NASDAQ:ICU) Trading 3.8% Higher – What’s Next?

SeaStar Medical Holding Corporation (NASDAQ:ICU) shot up 3.8% during trading on Monday . The stock traded as high as $3.49 and last traded at $3.24. 59,616 shares were traded during mid-day trading, a decline of 25% from the average session volume of 79,896 shares. The stock had previously closed at $3.12.

Analyst Ratings Changes

Several equities analysts recently issued reports on ICU shares. Wall Street Zen cut SeaStar Medical from a “hold” rating to a “sell” rating in a report on Saturday, May 16th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of SeaStar Medical in a research note on Tuesday, April 21st. Finally, Maxim Group set a $8.00 price objective on shares of SeaStar Medical and gave the company a “buy” rating in a research note on Thursday, May 14th. One investment analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $8.00.

SeaStar Medical Price Performance

The firm has a market cap of $12.96 million, a PE ratio of -0.67 and a beta of -1.05. The stock has a 50-day moving average price of $3.79 and a 200 day moving average price of $3.11.

SeaStar Medical (NASDAQ:ICU) last released its earnings results on Wednesday, May 13th. The company reported ($0.90) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.82) by ($0.08). The company had revenue of $0.49 million during the quarter, compared to analyst estimates of $0.44 million. SeaStar Medical had a negative return on equity of 146.29% and a negative net margin of 828.62%. As a group, equities research analysts anticipate that SeaStar Medical Holding Corporation will post -3.58 earnings per share for the current year.

Institutional Investors Weigh In On SeaStar Medical

Institutional investors have recently added to or reduced their stakes in the company. Millennium Management LLC acquired a new stake in SeaStar Medical during the third quarter worth about $102,000. Jane Street Group LLC acquired a new position in shares of SeaStar Medical in the 4th quarter valued at about $30,000. Finally, XTX Topco Ltd lifted its stake in shares of SeaStar Medical by 395.4% in the 2nd quarter. XTX Topco Ltd now owns 60,983 shares of the company’s stock valued at $26,000 after purchasing an additional 48,674 shares in the last quarter. Hedge funds and other institutional investors own 1.69% of the company’s stock.

About SeaStar Medical

SeaStar Medical, Inc (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies.

The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR.